Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
4.920
+0.030 (0.61%)
At close: Aug 26, 2026, 4:00 PM EDT
5.01
+0.09 (1.83%)
After-hours: Aug 26, 2026, 6:04 PM EDT
Evolent Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,097 | 1,876 | 2,555 | 1,964 | 1,352 | 907.96 | |
Revenue Growth | -4.50% | -26.56% | 30.09% | 45.26% | 48.91% | -1.80% |
Cost of Revenue | 1,735 | 1,476 | 2,187 | 1,503 | 1,035 | 657.55 |
Gross Profit | 361.64 | 399.88 | 367.35 | 460.47 | 316.58 | 250.41 |
Selling, General & Admin | 277.7 | 288.47 | 246.64 | 322.87 | 269.27 | 207.78 |
Operating Expenses | 389.47 | 404.32 | 343.41 | 446.29 | 336.46 | 267.82 |
Operating Income | -27.84 | -4.44 | 23.94 | 14.18 | -19.88 | -17.41 |
Interest Expense | -69.21 | -57.47 | -24.72 | -54.21 | -15.57 | -25.43 |
Interest & Investment Income | 3.55 | 4.19 | 5.54 | 5.26 | 1.37 | 0.41 |
Earnings From Equity Investments | 0.14 | 0.37 | -3.44 | 1.29 | 4.57 | 13.18 |
Other Non Operating Income (Expenses) | 0.38 | -53.1 | 0.07 | -62.53 | -45.89 | -0.15 |
EBT Excluding Unusual Items | -92.99 | -110.45 | 1.39 | -96 | -75.41 | -29.4 |
Merger & Restructuring Charges | -5.58 | -5.25 | -13.53 | -35.24 | - | -11.72 |
Impairment of Goodwill | -398 | -398 | - | - | - | - |
Gain (Loss) on Sale of Assets | 14.87 | 14.87 | - | -8.11 | - | 45.94 |
Asset Writedown | - | - | -24.19 | -24.07 | - | - |
Other Unusual Items | -20.44 | -35.8 | -26.71 | -38.99 | 13.33 | -34.62 |
Pretax Income | -502.14 | -534.64 | -63.04 | -202.41 | -62.08 | -29.8 |
Income Tax Expense | 2.85 | -0.13 | -1.41 | -89.37 | -43.38 | 0.48 |
Earnings From Continuing Operations | -504.99 | -534.51 | -61.62 | -113.04 | -18.7 | -30.28 |
Earnings From Discontinued Operations | - | - | - | - | -0.46 | -7.32 |
Net Income to Company | -504.99 | -534.51 | -61.62 | -113.04 | -19.16 | -37.6 |
Net Income | -504.99 | -534.51 | -61.62 | -113.04 | -19.16 | -37.6 |
Preferred Dividends & Other Adjustments | 6.07 | 44.89 | 31.83 | 29.22 | - | - |
Net Income to Common | -511.06 | -579.4 | -93.45 | -142.26 | -19.16 | -37.6 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 113 | 114 | 115 | 111 | 94 | 86 |
Shares Outstanding (Diluted) | 113 | 114 | 115 | 111 | 94 | 86 |
Shares Change | -2.39% | -0.41% | 3.08% | 18.73% | 8.87% | 1.34% |
EPS (Basic) | -4.54 | -5.07 | -0.81 | -1.28 | -0.20 | -0.44 |
EPS (Diluted) | -4.54 | -5.07 | -0.81 | -1.28 | -0.20 | -0.44 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 80.39 | 4.76 | -14.35 | 113.84 | -59.08 | 11.25 |
Free Cash Flow Per Share | 0.71 | 0.04 | -0.13 | 1.02 | -0.63 | 0.13 |
Gross Margin | 17.24% | 21.31% | 14.38% | 23.45% | 23.42% | 27.58% |
Operating Margin | -1.33% | -0.24% | 0.94% | 0.72% | -1.47% | -1.92% |
Profit Margin | -24.37% | -30.88% | -3.66% | -7.24% | -1.42% | -4.14% |
Free Cash Flow Margin | 3.83% | 0.25% | -0.56% | 5.80% | -4.37% | 1.24% |
EBITDA | 61.04 | 88.22 | 95.11 | 110.9 | 20.32 | 16.13 |
EBITDA Margin | 2.91% | 4.70% | 3.72% | 5.65% | 1.50% | 1.78% |
D&A For EBITDA | 88.87 | 92.65 | 71.17 | 96.72 | 40.2 | 33.54 |
EBIT | -27.84 | -4.44 | 23.94 | 14.18 | -19.88 | -17.41 |
EBIT Margin | -1.33% | -0.24% | 0.94% | 0.72% | -1.47% | -1.92% |